The Enterprise Value as of January 2026 (TTM) for Pasithea Therapeutics Corp. (KTTA) is 2.28M

According to Pasithea Therapeutics Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.28M. This represents a change of -200.60% compared to the average of -2263609.64 of the last 4 quarters.

Pasithea Therapeutics Corp. (KTTA) Historical Enterprise Value (quarterly & annually)

How has KTTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Pasithea Therapeutics Corp. over the last ten years is 1.96M. The current 2.28M Enterprise Value has changed 11.51% with respect to the historical average. Over the past ten years (40 quarters), KTTA's Enterprise Value was at its highest in in the June 2021 quarter at 48.48M. The Enterprise Value was at its lowest in in the June 2022 quarter at -23801850.80.

Pasithea Therapeutics Corp. (KTTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pasithea Therapeutics Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pasithea Therapeutics Corp. (KTTA) Average Enterprise Value

How has KTTA Enterprise Value performed in the past?

The current Enterprise Value of Pasithea Therapeutics Corp. (KTTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pasithea Therapeutics Corp. (KTTA) Enterprise Value vs. Peers

How is KTTA’s Enterprise Value compared to its peers?

Pasithea Therapeutics Corp.’s Enterprise Value is less than Quoin Pharmaceuticals, Ltd. (3.05M), less than Impact BioMedical Inc. (28.82M), less than KALA BIO, Inc. (20.69M), less than AIM ImmunoTech Inc. (3.37M), less than Alaunos Therapeutics, Inc. (4.20M), greater than VYNE Therapeutics Inc. (-9905334.00), greater than VivoSim Labs, Inc. (-1543465.00), greater than Cyclerion Therapeutics, Inc. (4.29K), greater than Polyrizon Ltd. (-2161198.00), less than NovaBay Pharmaceuticals, Inc. (232.08M),

Build a custom stock screener for Pasithea Therapeutics Corp. (KTTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pasithea Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pasithea Therapeutics Corp. (KTTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pasithea Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.